Biogen | Eigenkapital Und Reserven

Equity Capital And Reserves Veränderung Datum
AbbVie USD 12.09B 772M 2023-09
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
ALKERMES USD 1.36B 75.15M 2023-09
Amgen USD 6.23B 1.42B 2023-12
Bayer EUR 33.38B 3.57B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
Incyte USD 5.19B 258.39M 2023-12
Intra Cellular Therapies USD 591.42M 9.26M 2023-12
Moderna USD 13.85B 399M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
PTC Therapeutics USD -818555000 147.74M 2023-12
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Teva Pharmaceutical Industries USD 6.93B 122M 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
United Therapeutics USD 5.98B 272.7M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Biogen Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.